Search company, investor...
Treato company logo

Treato

treato.com

Founded Year

2011

Stage

Dead | Dead

Total Raised

$14.5M

About Treato

Treato generates the 'Voice of the Patient' by collecting and analyzing billions of online patient conversations in real-time and on a massive scale. The Treato patient intelligence platform offers both patients and healthcare stakeholders unique insights based on the aggregated wisdom of the crowd through its free patient site, treato.com, and its professional service offering, Treato Pharma, covering over 1.3 billion patient discussions about 24,000 drugs and conditions.

Headquarters Location

9 Ha'atzmaut Road

Tel Aviv,

Israel

+972 77-4430054

Missing: Treato's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Treato's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Treato

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Treato in 1 CB Insights research brief, most recently on Jan 23, 2023.

Treato Patents

Treato has filed 5 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/5/2011

12/17/2013

Atlantic tropical storms, Consumer rights activists, Promotion and marketing communications, Effects of hurricanes, Medical specialties

Grant

Application Date

10/5/2011

Grant Date

12/17/2013

Title

Related Topics

Atlantic tropical storms, Consumer rights activists, Promotion and marketing communications, Effects of hurricanes, Medical specialties

Status

Grant

Latest Treato News

Treato, a Startup that Wanted to Replace Dr. Google, Shuts Down

Aug 14, 2018

Treato, a Startup that Wanted to Replace Dr. Google, Shuts Down Launched in 2011, Treato operated a platform designed to gather and analyze user-generated health-related information and offer insights on medical conditions and medication Meir Orbach 18:5914.08.18     Founded in 2011 by Gideon Mantel and Ido Hadari, who served as the company’s CEO, Treato operated a platform designed to gather and analyze user-generated health-related information as well as professional medical advice and offer insights on medical conditions, symptoms, and medication. Before shutting down, Treato employed ten people in Israel and the U.S. The company employed a team of 20 in 2012, and as many as 46 employees in its heyday, between the years 2013 and 2015. Photo: Amit Sha'al In court documents reviewed by Calcalist the company stated it was unable to secure sufficient funding or get an acquisition offer, and that it is in a state of insolvency. The company reported $352,716 (NIS 1.3 million) in assets and a debt of $8.4 million (NIS 31 million). Treato has raised $35.5 million in funding, according to Pitchbook data. New Leaf Venture Partners, OrbiMed, REV Venture Partners, and Western Technology Investment are some of the company’s investors. In 2015 and in 2016, Treato called on its stakeholders for two rounds of debt financing and was able to raise an additional $8.75 million. A 2016 cost-cutting program that saw Treato shed a third of its workforce, shut down a New York office, and hire strategic consultants did not cut it, with New Leaf dropping as a backer in 2017. Treato attempted to streamline its operations further, letting go half of its remaining employees and shutting down a New Jersey office. At the same time, it negotiated an acquisition deal with an undisclosed potential buyer, which ultimately fell through. Mantel was the co-founder and long-time CEO of Commtouch Ltd., a company founded in 1991 as an email service provider. The company debuted on Nasdaq in late 1990’s, reaching a market capitalization of $1 billion in 2000 before crashing all the way down to a $2 million market capitalization in 2002. Later, the company managed to reinvent itself as an antivirus developer and climbed back to a $100 million market capitalization. Hadari took over as Commtouch CEO in 2010. In 2014, the company rebranded as Cyren. Related stories: On Tuesday, a source familiar with the matter told Calcalist on condition of anonymity that Israeli insights company Signals Analytics Inc. intends to hire Treato’s research and development team. Signals Analytics develops an analytics platform designed to offer insights into the development processes of pharmaceuticals and consumer products. In response to Calcalist’s request for comment, Signals CEO Gil Sadeh said that while he cannot comment on hiring processes, his company has known the Treato team for years and values its technical prowess, if not its product development abilities. Sadeh added that Signals had increased its team of developers recently. CancelSend

Treato Frequently Asked Questions (FAQ)

  • When was Treato founded?

    Treato was founded in 2011.

  • Where is Treato's headquarters?

    Treato's headquarters is located at 9 Ha'atzmaut Road, Tel Aviv.

  • What is Treato's latest funding round?

    Treato's latest funding round is Dead.

  • How much did Treato raise?

    Treato raised a total of $14.5M.

  • Who are the investors of Treato?

    Investors of Treato include OrbiMed Advisors, New Leaf Venture Partners, REV Venture Partners, Western Technology Investment and Shmuel Cabily.

  • Who are Treato's competitors?

    Competitors of Treato include Px HealthCare and 4 more.

Compare Treato to Competitors

Nuna Logo
Nuna

Nuna is a healthcare technology company that seeks to help make high-quality healthcare affordable and accessible for everyone. The company does this by building data solutions for healthcare payers and providers to measure and improve their cost and quality outcomes.

Syapse Logo
Syapse

Syapse develops software for aggregating and structuring biomedical data. It combines data intelligence, insight analytics and applied experience through healthcare organizations looking to transform patients’ lives using real-world evidence. The company was founded in 2008 and is based in San Francisco, California.

COTA Logo
COTA

COTA provides healthcare services for cancer-affected patients. It combines its proprietary technology and analytics solutions to inform decisions and actions. COTA partners with life sciences companies to reveal insights to accelerate drug development and helps uncover previously unknown insights. The company was founded in 2011 and is based in Boston, Massachusetts.

Healthjump Logo
Healthjump

Healthjump provides a cloud-hosted platform for the collection, standardization, and delivery of EHR/EMR data into applications, analytics, clinical research, quality measures reporting, and more without the complex set-up of traditional interface engines. Healthjump was founded in 2013 and is based in King of Prussia, Pennsylvania.

U
UCARE.AI

UCARE.AI uses data ethically to solve real-world problems and improve lives. It aims to apply its predictive engine to all aspects of the healthcare industry, to help patients, providers, caregivers, and payers manage patients throughout the lifecycle of their diseases at lower costs. It was founded in 2016 and is based in Singapore, Singapore.

Lumeris Logo
Lumeris

Lumeris operates as an accountable care delivery company that offers health systems, payers and providers operational support, technology and consulting services. Essence Group Holdings Corporation (EGHC) is the holding company of Lumeris.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.